Form D · Biotechnology
Aspira Women's Health Inc.
Austin, TX · CIK 0000926617
Offering snapshot reported Jun 22, 2026 · SEC filing
- Reported sold
- $1.49M Offering amount: $1.49M
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 5, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 22, 2026 | Initial | $1,485,000 | No comparison | 19 | SEC filing |
| Mar 20, 2025 | Initial | $1,370,000 | No comparison | 27 | SEC filing |
| Feb 7, 2024 | Initial | $6,488,230 | No comparison | 7 | SEC filing |
| Jul 15, 2020 | Initial | $11,025,000 | No comparison | 8 | SEC filing |
| May 24, 2013 | Initial | $13,242,500 | No comparison | 11 | SEC filing |
| Jan 12, 2010 | Initial | $43,049,858 | No comparison | 14 | SEC filing |
| Sep 17, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Sep 14, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 30, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 4, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-588025
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| None | None |
Source: Form D, filed Jun 22, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ellen Beausang | Director |
| Robert Beechey | Executive |
| Jody Berry | Executive |
| Michael Buhle | Executive |
| James S. Burns | Director |
| Stefanie Cavanaugh | Director |
| Nancy G. Cocozza | Director |
| Jeffrey Cohen | Director |
| James Crawford | Executive |
| William Creech | Executive |
| Celeste Fralick | Director |
| John Fraser | Director, Executive |
| Robert Goggin | Director |
| John F. Hamilton | Director |
| Jannie Herchuk | Director |
| Torsten Hombeck | Executive |
| Bruce Huebner | Director |
| Cynthia Hundorfean | Director |
| Veronica G. H. Jordan | Director |
| James T. La France | Director |
| Thomas Mc Lain | Executive |
| Minh Merchant | Executive |
| Donald Munroe | Executive |
| Ellen O'connor Vos | Director |
| Lynn O'connor Vos | Director |
| Gail S. Page | Director |
| Valerie B. Palmieri | Director, Executive |
| Winfred Parnell | Director |
| John Ragard | Director |
| Peter Roddy | Director |
| Nicole Sandford | Director, Executive |
| Eric Schoen | Executive |
| David R. Schreiber | Director |
| Carl Severinghaus | Director |
| John Strahley | Executive |
| William Wallen | Director |
| Jane Pine Wood | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
12117 Bee Caves Road Building Iii, Suite 100
Austin, TX, 78738
Austin, TX, 78738